16,716 Shares in Agilent Technologies, Inc. $A Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp acquired a new stake in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 16,716 shares of the medical research company’s stock, valued at approximately $2,220,000.

A number of other large investors have also modified their holdings of A. Fiduciary Trust Co boosted its stake in shares of Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares in the last quarter. Sapient Capital LLC grew its holdings in Agilent Technologies by 4.2% during the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after acquiring an additional 85 shares during the period. Plan A Wealth LLC raised its position in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after acquiring an additional 92 shares in the last quarter. UNIVEST FINANCIAL Corp raised its position in Agilent Technologies by 1.3% in the second quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock worth $949,000 after acquiring an additional 93 shares in the last quarter. Finally, IHT Wealth Management LLC lifted its holdings in Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares during the period.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on A. TD Cowen upped their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Morgan Stanley upped their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Finally, Barclays increased their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Agilent Technologies Stock Performance

NYSE:A opened at $155.16 on Thursday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $43.82 billion, a P/E ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. The firm has a 50-day moving average price of $139.16 and a two-hundred day moving average price of $126.65. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the business earned $1.37 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.